MoonLake Immunotherapeutics beat EPS estimates 0% of the time across 1 reported quarters (0 beats, 1 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.93 | — | — | Miss |
| Q12026 FY2026 | $-0.91 | $-0.98 | -7.7% | Miss |
| 2026-02-25 | $-0.97 | — | — | Miss |
Back to MLTX overview · MLTX holders · MLTX KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.